ANTRIL
USPTO Trademark Record · Serial No. 74478239
Trademark details
It was initially claimed by Synergen, Inc. on 19940110.
That brand applies to the following goods and services:pharmaceuticals, including protein-based and other pharmaceuticals for use in treating diseases, including inflammatory diseases, chronic skin ulcers, neurological disorders, rheumatoid arthritis, sepsis and septic shock, leukemia, cystic fibrosis, genetic emphysema and peripheral neuropathies, sepsis syndrome; systemic inflammatory response syndrome ( SIRS) due to sepsis; pancreatitis; burns and cachexia; asthma; inflammatory bowel disease; graft versus host disease; and stroke; IL-1 mediated d.
Currently that trademark is represented by trademark attorney(s): Jay H. Begler.
You can learn more about that trademark on the USPTO website: View the USPTO record
Services available
Questions about this trademark?
If you have questions or issues related to the ANTRIL trademark — or to trademarks in general — our trademark attorneys can help. No appointment needed: call us or request a free estimate.
Register a Trademark Get a Free Estimate
